Kwality Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)
Kwality Pharmaceuticals Ltd · Financial Result · 12 Nov 2026, 6:25 pm
Kwality Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) ■ Revenue: 18,122 (+63.2% YoY | +11.6% QoQ) ■ EBITDA: 4,980 (+96.4% YoY | +21.4% QoQ) ■ EBITDA Margin (%): 27.5 (+465 bps YoY | +222 bps QoQ) ■ PAT: 2,903 (+105.6% YoY | +13.3% QoQ) ■ EPS (INR): 27.9 (+105.4% YoY | +13.1% QoQ)
Original exchange filing (PDF)
More announcements from Kwality Pharmaceuticals Ltd
- Transcript of Earnings Conference Call - Q2FY2027 · 16 Nov 2026
- Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Recording of Investor/ Analyst Earnings Call held on November 13, 2026 · 14 Nov 2026
- Intimation under Regulation 30 of the SEBI(LODR), 2015 -Recording of Investor/ Analyst Earnings Call held on September 13, 2026 · 14 Nov 2026
- Investor Presentation for the quarter and half year ended unaudited financial results for 30-09-2026 · 12 Nov 2026
- Appointment of new Statutory Auditors · 12 Nov 2026
- Resignation of Statutory Auditor · 12 Nov 2026
- Approval of Unaudited Financial Results for the quarter and half year ended 30-09-2026. · 12 Nov 2026
- Intimation of Earnings Conference Call for Q2 FY 2026-27 & REVISED LINK FOR REGISTRATION · 13 Nov 2026
